In Veritas Medical Stock Analysis
| IVME Stock | USD 0.0001 0.00 0.00% |
In Veritas Medical is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of In Veritas stock analysis is to determine its intrinsic value, which is an estimate of what In Veritas Medical is worth, separate from its market price. There are two main types of In Veritas' stock analysis: fundamental analysis and technical analysis.
The In Veritas stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and In Veritas' ongoing operational relationships across important fundamental and technical indicators.
IVME |
IVME Stock Analysis Notes
The company recorded a loss per share of 0.01. In Veritas Medical had not issued any dividends in recent years. The entity had 9.009:1 split on the 23rd of June 2004. In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with near-patient testing applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. IN Veritas operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 7 people. To learn more about In Veritas Medical call G Cooper at 44 14 6366 7347.In Veritas Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. In Veritas' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding In Veritas Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| In Veritas Medical generated a negative expected return over the last 90 days | |
| In Veritas Medical has some characteristics of a very speculative penny stock | |
| In Veritas Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In Veritas generates negative cash flow from operations | |
| In Veritas Medical has a frail financial position based on the latest SEC disclosures |
IVME Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.61 K.IVME Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (257.37) | (244.50) | |
| Return On Capital Employed | (0.39) | (0.40) | |
| Return On Assets | (37.71) | (35.82) | |
| Return On Equity | 0.47 | 0.30 |
Management Efficiency
In Veritas Medical has return on total asset (ROA) of (6.4797) % which means that it has lost $6.4797 on every $100 spent on assets. This is way below average. In Veritas' management efficiency ratios could be used to measure how well In Veritas manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -244.5. In addition to that, Return On Capital Employed is expected to decline to -0.4. At present, In Veritas' Debt To Assets are projected to increase based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 88.52, whereas Net Tangible Assets are forecasted to decline to (6.7 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.12) | (0.11) | |
| Tangible Book Value Per Share | (0.12) | (0.11) | |
| Enterprise Value Over EBITDA | (1.31) | (1.38) | |
| Price Book Value Ratio | (0.04) | (0.04) | |
| Price Fair Value | (0.04) | (0.04) | |
| Enterprise Value Multiple | (1.31) | (1.38) | |
| Enterprise Value | 4.5 M | 4.3 M |
In Veritas Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 9.03 | Return On Assets (6.48) |
Technical Drivers
In Veritas Medical technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.In Veritas Medical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. In Veritas middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for In Veritas Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About IVME Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how In Veritas prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IVME shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as In Veritas. By using and applying IVME Stock analysis, traders can create a robust methodology for identifying IVME entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.67) | (1.76) | |
| Operating Profit Margin | 0.87 | 1.71 | |
| Net Loss | (1.67) | (1.76) | |
| Gross Profit Margin | 1.14 | 1.10 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding In Veritas to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |